$MRK $GILD $BMY 
All vying for a piece of TIGIT 🎂 

$PHIO $11M could see a big pharma deal

Street snoozing like on $ALPN
Is a powerhouse Merck team preparing to leap past Roche — &amp; leave Gilead &amp; Bristol Myers behind — in the race to TIGIT domination?  https://t.co/DDw0bqmD8J